The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.675
Bid: 18.35
Ask: 19.95
Change: 0.00 (0.00%)
Spread: 1.60 (8.719%)
Open: 18.675
High: 0.00
Low: 0.00
Prev. Close: 18.675
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dividend Declaration

4 Jan 2022 07:00

RNS Number : 2467X
BATM Advanced Communications Ld
04 January 2022
 

LEI: 213800FLQUB9J289RU66

4 January 2022

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Dividend Declaration

Further to the Group's announcement of 14 December 2021, BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, gives notice of how eligible shareholders who are not Israeli tax residents can apply for, and benefit from, a reduced withholding tax rate with regards to the dividend payment.

 

Withholding Tax Rate

 

In accordance with Israeli tax regulation, the Group will withhold at source 16.74% (the "Withholding Tax Rate") of the gross amount of the dividend. Shareholders or holders of depositary interests in respect of ordinary shares in the Company who are subject to a lower withholding tax rate as a resident of a country with which Israel has a treaty for the avoidance of double taxation, such as the UK, may be eligible to benefit from a reduced withholding tax rate ("Eligible Shareholder").

 

Under the Double Taxation Treaty between Israel and the UK, a shareholder or depositary interest holder who is a British tax resident (and does not have a permanent establishment in Israel) and whose dividend income is subject to tax in the UK, is entitled to a reduced withholding tax rate of 15.00% or 5.00% if the beneficial owner of the dividend is a company (the "Reduced Withholding Tax Rate").

 

Dividend Payment Process and Applying for Reduced Withholding Tax Rate

 

The Group has appointed IBI Trust Management as its trustee and sub-paying agent (the "Tax Trustee"). The Group will transfer 16.74% of the gross amount of the dividend to the Tax Trustee and the remaining balance will be paid to shareholders or depositary interest holders through Link Group or a shareholder's relevant broker.

 

Eligible Shareholders can apply to the Tax Trustee to reclaim the difference between the amount withheld in accordance with the Withholding Tax Rate and the amount that would be withheld if the Reduced Withholding Tax Rate (or equivalent rate for Eligible Shareholders in jurisdictions other than the UK) were applied.

 

To apply for a reduced withholding tax rate, Eligible Shareholders must deliver to the Tax Trustee, via the email address below, scanned copies of specified tax residency and banking documentation and a completed application form (the "Application") by 15 February 2022 (the "Application Deadline"). The documents required to be included in the Application are detailed in the application form, which is available for download at the following link or by contacting the Tax Trustee:

 

https://www.batm.com/media/1486/tax-withholding-form.pdf

 

The Tax Trustee will review the Applications and refund to Eligible Shareholders, who submitted approved and complete Applications by the Application Deadline, any excess tax withheld in accordance with any applicable reduced withholding tax rate. Following the repayments of such refunds, the Tax Trustee will remit all remaining funds to the Israel Tax Authority.

 

Tax Trustee Contact Information

 

The contact information for the Tax Trustee, including the email address for submitting Applications, is as follows:

 

IBI Trust Management

Address: 9 Ehad Ha'am (Shalom Tower), Tel Aviv, Israel

Email: IBI-CM@IBI.co.il 

Phone: +972 506 209 410

 

 

Shareholders are advised to consult with their own personal tax and financial advisers as to the tax consequences resulting from their personal tax situation.

 

 

Enquiries:

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

Henry Willcocks (Corporate Broking)

+44 20 7408 4050 

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVUPURPGUPPGAW
Date   Source Headline
2nd May 20247:00 amRNSBATM selected for TB diagnostics programme
18th Apr 20247:00 amRNSBATM to deliver Edgility to new Tier 1 customer
8th Apr 20247:00 amRNSBATM awarded new Edgility contract from Cemex
3rd Apr 20247:00 amRNSAnnual Financial Report
26th Mar 20247:00 amRNSBATM receives $2.3m cyber security orders
12th Mar 20247:00 amRNSFull Year Results
29th Feb 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
30th Nov 20237:03 amRNSBlock Listing Application
27th Nov 20237:00 amRNSBlock Listing Interim Review
30th Oct 20237:00 amRNSBATM receives $3m cyber security order
23rd Oct 20237:00 amRNSADOR Diagnostics secures $7.5m investment
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20237:00 amRNSNew Edgility order for US Emergency Services
9th Oct 20237:00 amRNSResponse to recent developments in Israel
6th Sep 20237:00 amRNSBATM receives $3.4m cyber security contract
29th Aug 20237:00 amRNSInterim Results
13th Jul 202311:30 amRNSResult of AGM and Director Appointment
8th Jun 20237:00 amRNSNotice of Annual General Meeting
6th Jun 20237:00 amRNSCapital Markets Day
5th Jun 20237:00 amRNSNew contract win for Edgility
10th May 20232:30 pmRNSCapital Markets Day and Investor Presentation
17th Apr 20237:00 amRNSEdgility rollout progressing ahead of schedule
4th Apr 20233:30 pmRNSAnnual Financial Report
6th Mar 20237:00 amRNSFull Year Results
24th Feb 20237:00 amRNSNotice of Results
1st Feb 20237:00 amRNSAppointment of Chief Financial Officer
9th Jan 20237:00 amRNSBATM receives $26m cyber security order
3rd Jan 20233:30 pmRNSGrant of Options
21st Dec 202212:00 pmRNSResult of AGM
21st Dec 20227:00 amRNSTransaction in Own Shares and TVR
20th Dec 20227:00 amRNSTransaction in Own Shares and TVR
19th Dec 20227:00 amRNSTransaction in Own Shares and TVR
16th Dec 20227:00 amRNSTransaction in Own Shares and TVR
15th Dec 20227:00 amRNSTransaction in Own Shares and TVR
14th Dec 20227:00 amRNSTransaction in Own Shares and TVR
13th Dec 20227:00 amRNSTransaction in Own Shares and TVR
9th Dec 20227:00 amRNSTransaction in Own Shares and TVR
8th Dec 20227:00 amRNSTrading Update
25th Nov 20221:00 pmRNSBlock Listing Interim Review
24th Nov 20224:00 pmRNSNotice of Annual General Meeting
27th Oct 20227:00 amRNSADOR and BIOASTER to develop STI diagnostic tests
18th Oct 20227:00 amRNSMulti-year contract with CityFibre for Edgility
6th Oct 20227:00 amRNSDirectorate Changes
24th Aug 20227:00 amRNSInterim Results
19th Jul 20227:00 amRNSAppointment of CEO of ADOR Diagnostics
11th Jul 20227:00 amRNSBATM partners with CityFibre for Edgility
16th Jun 20224:36 pmRNSPrice Monitoring Extension
26th May 20227:00 amRNSBlock Listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.